The diagnostic value of cerebrospinal fluid chemokine c-x-c motif ligand 13 (CSF CXCL13) for neurosyphilis was assessed by meta-analysis in this study. PubMed, Web of Science and Embase databases were searched to identify relevant articles by using MeSH and free terms of CXCL13 and neurosyphilis. A total of 720 syphilis and 338 neurosyphilis individuals in 6 articles were involved in this meta-analysis. The pooled sensitivity and specificity were 0.82 (95% confidence intervals (CI), 0.77–0.87) and 0.84 (95% CI, 0.79–0.87). The pooled positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio and the area under receiver operating characteristic curve were 5.10 (95% CI, 3.90–6.60), 0.21 (95% CI, 0.16–0.28), 24.00 (95% CI, 14.00–39.00) and 0.88 (95% CI, 0.84–0.90), respectively. In subgroup analysis, human immunodeficiency virus infection and diagnostic criteria for neurosyphilis were identified to be associated with heterogeneity. Based on limited evidence, CSF CXCL13 can be helpful in diagnosing neurosyphilis.
JanierMUnemoMDupinN, et al.2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol2021;35(3):574–588. DOI: 10.1111/jdv.16946
RopperAH. Neurosyphilis. N Engl J Med2019; 381(14): 1358–1363. DOI: 10.1056/NEJMra1906228.
4.
TuddenhamSGhanemKG. Neurosyphilis: knowledge gaps and controversies. Sex Transm Dis2018; 45(3): 147–151. DOI: 10.1097/OLQ.0000000000000723.
5.
DragoFAgnolettiAFCiccareseG, et al.Two cases of oligosymptomatic neurosyphilis in immunocompetent patients: atypical neurosyphilis presentation. Int J STD AIDS2016; 27(2): 155–156. DOI: 10.1177/0956462415578546.
6.
CozzaniEGaspariniGCiccareseG, et al.Concurrent benign tertiary syphilis and asymptomatic neurosyphilis in an immunocompetent patient. J Eur Acad Dermatol Venereol2021; 35(2): e151–e152. DOI: 10.1111/jdv.16882.
7.
DavisLESchmittJW. Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol1989; 25(1): 50–55. DOI: 10.1002/ana.410250108.
8.
EbisunoYTanakaTKanemitsuN, et al.Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer’s patches and affects B cell trafficking across high endothelial venules. J Immunol2003; 171(4): 1642–1646. DOI: 10.4049/jimmunol.171.4.1642.
9.
RupprechtTAPlateAAdamM, et al.The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation2009; 6: 42. DOI: 10.1186/1742-2094-6-42.
10.
KrumbholzMTheilDCepokS, et al.Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain2006; 129(Pt 1): 200–211. DOI: 10.1093/brain/awh680.
11.
RubensteinJLWongVSKadochC, et al.CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood2013; 121(23): 4740–4788. DOI: 10.1182/blood-2013-01-476333.
12.
YuQChengYWangY, et al.Aberrant humoral immune responses in neurosyphilis: CXCL13/CXCR5 play a pivotal role for B-cell recruitment to the cerebrospinal fluid. J Infect Dis2017; 216(5): 534–544. DOI: 10.1093/infdis/jix233.
13.
LiXXZhangJWangZY, et al.Increased CCL24 and CXCL7 levels in the cerebrospinal fluid of patients with neurosyphilis. J Clin Lab Anal2020; 34(9): e23366. DOI: 10.1002/jcla.23366.
14.
MarraCMTantaloLCSahiSK, et al.CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis2010; 37(5): 283–287. DOI: 10.1097/OLQ.0b013e3181d877a1.
15.
HuRLuCLuS, et al.Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients. Int J STD AIDS2016; 27(2): 141–146. DOI: 10.1177/0956462415577229.
16.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev2021; 10(1): 89. DOI: 10.1186/s13643-021-01626-4.
17.
WhitingPFRutjesAWWestwoodME, et al.QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med2011; 155(8): 529–536. DOI: 10.7326/0003-4819-155-8-201110180-00009.
18.
LinL. Comparison of four heterogeneity measures for meta-analysis. J Eval Clin Pract2020; 26(1): 376–384. DOI: 10.1111/jep.13159.
19.
LiDHuangXShiM, et al.Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis. Sex Transm Infect2021; 97(7): 485–489. DOI: 10.1136/sextrans-2020-054778.
20.
MarraCM. Alternatives to the cerebrospinal fluid venereal disease research laboratory test for neurosyphilis diagnosis. Sex Transm Dis2021; 48(8S): S54–S57. DOI: 10.1097/OLQ.0000000000001450.
21.
MothapoKMVerbeekMMvan der VeldenLB, et al.Has CXCL13 an added value in diagnosis of neurosyphilis?J Clin Microbiol2015; 53(5): 1693–1696. DOI: 10.1128/JCM.02917-14.
22.
WangCWuKYuQ, et al.CXCL13, CXCL10 and CXCL8 as potential biomarkers for the diagnosis of neurosyphilis patients. Sci Rep2016; 6: 33569. DOI: 10.1038/srep33569.
23.
YangLFuYLiS, et al.Analysis of treponema pallidum DNA and CXCL13 in cerebrospinal fluid in HIV-negative syphilis patients. Infect Drug Resist2022; 15: 7791–7798. DOI: 10.2147/IDR.S394581.
24.
ZengYLLinYQZhangNN, et al.CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients. Springerplus2016; 5(1): 743. DOI: 10.1186/s40064-016-2462-4.
25.
ZhuLGuXPengRR, et al.Comparison of the cerebrospinal fluid (CSF) toluidine red unheated serum test and the CSF rapid plasma reagin test with the CSF venereal disease research laboratory test for diagnosis of neurosyphilis among HIV-negative syphilis patients in China. J Clin Microbiol2014; 52(3): 736–740. DOI: 10.1128/JCM.02522-13.
26.
RupprechtTAManzKMFingerleV, et al.Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis. Clin Microbiol Infect2018; 24(12): 1234–1240. DOI: 10.1016/j.cmi.2018.04.007.
27.
MarraCMMaxwellCLSmithSL, et al.Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis2004; 189(3): 369–376. DOI: 10.1086/381227.
28.
TaylorMMAynalemGOleaLM, et al.A consequence of the syphilis epidemic among men who have sex with men (MSM): neurosyphilis in Los Angeles, 2001–2004. Sex Transm Dis2008; 35(5): 430–434. DOI: 10.1097/OLQ.0b013e3181644b5e.
29.
LukehartSAHookEW3rdBaker-ZanderSA, et al.Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med1988; 109(11): 855–862. DOI: 10.7326/0003-4819-109-11-855.
30.
BremellDMattssonNEdsbaggeM, et al.Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol2013; 13: 2. DOI: 10.1186/1471-2377-13-2.
31.
JaeschkeRGuyattGHSackettDL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group. JAMA1994; 271(9): 703–707. DOI: 10.1001/jama.271.9.703.
32.
YanYWangJQuB, et al.CXCL13 and TH1/Th2 cytokines in the serum and. cerebrospinal fluid of neurosyphilis patients. Medicine (Baltim)2017; 96(47): e8850. DOI: 10.1097/MD.0000000000008850.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
